Nos publications

Platform technology for introducing liquid solubilizers in tablet formulations

  • Poster

AAPS - oct 2024

Ketkee Deshmukh, Vitthal N. Gadlawar, Devanshi S. Shah, Swapnil Mohurle, Sunil Bambarkar

Lipid-based excipients, which are often liquid at room temperature, can enhance solubility and permeation. This study aims to incorporate a liquid lipid excipient into a solid dosage form for the poorly water-soluble drug ondansetron hydrochloride dihydrate (OHD).

Advantages of combining polymers and lipids in extrusion processes

  • Poster

PBP - mar 2024

Ceren Yüce, Lolie Cheron, Anja Geissler-Fichtner, Elsa Gattefossé

Lipid excipients lower the glass transition temperature of polymers, enabling hot-melt extrusion at lower engine torque for better processability. Different polymers and lipid combinations have been tested to explore their potential in extrusion processes.

Impact of Granulation Solvent on Release Performance of Dual Matrix Extended-Release Tablets of Highly Water Soluble Drugs Formulated using Compritol® 888 ATO and Methocel® as Release Retarding Agents

  • Poster

AAPS PharmSci360 – Boston (USA)  - oct 2022

Ketkee Deshmukh, Swarnadeep Banerjee, Agnivesh Shrivastava, Sunil Bambarkar

The purpose of this study is to evaluate the impact of different granulation solvents on the performance of dual extended- release matrix tablets, formulated using a combination of Compritol® 888 ATO and Methocel® K100M, with two model APIs:

- highly water-soluble high dose (1000 mg) Metformin Hydrochloride

- freely water-soluble low dose (95 mg) Metoprolol Succinate

Exploring the Potential of Compritol® 888 ATO for Abuse Deterrent Sustained Release Tablets

  • Poster

CRS Annual Meeting – Montreal (Canada)  - jui 2022

Agnivesh Shrivastava ; Renuka Tiwari ; Ketkee Deshmukh and Sunil Bambarkar

Selecting efficient pharmaceutical binder for developing robust extended-release matrices of Compritol® 888 ATO prepared using wet granulation technique: Part 2 Studying impact on dissolution profiles of ER tablets of different API’s

  • Poster

CRS Annual Meeting - virtual  - jui 2021

K. Deshmukh1, A. Shrivastava1, S. Banerjee1, R. Tiwari1, S. Bambarkar1, N. Farah2 1Gattefosse India Pvt. Ltd., Mumbai, INDIA, 2Gattefosse SAS, Lyon, FRANCE

Selecting efficient pharmaceutical binder for developing robust extended-release matrices of Compritol® 888 ATO prepared using wet granulation technique: Part 1 Studying impact on granule & tablet properties

  • Poster

CRS Annual Meeting - virtual  - jui 2021

K. Deshmukh, A. Shrivastava, S. Banerjee, R. Tiwari, S. Bambarkar, N. Farah Gattefosse India Pvt. Ltd., Mumbai, INDIA, Gattefosse SAS, Lyon, FRANCE

Selecting efficient pharmaceutical binder for developing robust extended-release matrices of Compritol® 888 ATO prepared using wet granulation technique: Part 1 Studying impact on granule & tablet properties

  • Poster

CRS Annual Meeting - virtual - jui 2021

K. Deshmukh, A. Shrivastava, S. Banerjee, R. Tiwari, S. Bambarkar, N. Farah Gattefosse India Pvt. Ltd., Mumbai, INDIA, Gattefosse SAS, Lyon, FRANCE

Evolution of the Microstructure of Sustained-release Matrix Tablets during Dissolution and Storage

  • Scientific publication

Indian J Pharm Sci 2018;80(6):1011-1020 - sep 2018

V. Jannin, E. Leccia, Y. Rosiaux, J. Doucet

QbD - How particle size and glyceride composition affect the performance of sustained-release tablets with Compritol 888 ATO

  • Poster

AAPS Annual Meeting & Exposition – San Diego (USA)  - nov 2017

Yvonne Rosiaux, Amandine Forrest, Jean-Michel Girard, Carole Deleglise, Delphine Marchaud